Jazz Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for JAZZ PHARMS INC, and when can generic versions of JAZZ PHARMS INC drugs launch?
JAZZ PHARMS INC has one approved drug.
There are three US patents protecting JAZZ PHARMS INC drugs.
There are twenty-four patent family members on JAZZ PHARMS INC drugs in sixteen countries.
Summary for Jazz Pharms Inc
| International Patents: | 24 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Jazz Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharms Inc | DEFITELIO | defibrotide sodium | SOLUTION;INTRAVENOUS | 208114-001 | Mar 30, 2016 | RX | Yes | Yes | 11,236,328 | ⤷ Subscribe | ⤷ Subscribe | ||||
| Jazz Pharms Inc | DEFITELIO | defibrotide sodium | SOLUTION;INTRAVENOUS | 208114-001 | Mar 30, 2016 | RX | Yes | Yes | 11,746,348 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| Jazz Pharms Inc | DEFITELIO | defibrotide sodium | SOLUTION;INTRAVENOUS | 208114-001 | Mar 30, 2016 | RX | Yes | Yes | 11,085,043 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Jazz Pharms Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2015521477 | ⤷ Subscribe |
| European Patent Office | 2864496 | ⤷ Subscribe |
| South Korea | 20180098420 | ⤷ Subscribe |
| Hong Kong | 1208503 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
